Don't want ads? Subscribe or login now.

FDA Yanks Ozone-Depleting Inhaler From Market

By Greg Ryan · September 22, 2011, 3:24 PM EDT

The U.S. Food and Drug Administration announced Thursday it was taking the only agency-approved over-the-counter asthma inhaler off the market at the end of the year because it uses a compound...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Greg

March 21, 2014
Attys Bash Aetna's Bid For Garlock Asbestos Claimants Info
January 17, 2014
Surgeon General Links Smoking To Diabetes, Liver Cancer
January 10, 2014
Legal Pot Leaves Product Liability Attys Dazed, Confused
December 16, 2013
Stryker Hip Implant Suit Stays In Federal MDL
November 18, 2013
Senate Approves Drug Compounding Reform Bill
November 04, 2013
With $2B J&J Deal, FCA Proves It's Still The Anti-Fraud King
October 31, 2013
Tobacco Cos. Lose Bid To Oust Counsel In Canadian Suit
October 29, 2013
UK To Ban Hospitals' Use Of Many Metal Hip Implants
September 19, 2013
4 Ways To Make Sure Comments On Agency Rules Count
August 08, 2013
Compounder Wins Transfer Of Eye Injury Suits To La.

FDA Yanks Ozone-Depleting Inhaler From Market

Related Sections

Recent Articles By Greg